Tom Dubin is an attorney, consultant and investor. From 2001 through 2013, he was a member of the executive committee of Alexion Pharmaceuticals, Inc., an S&P 500 biopharmaceuticals company that discovers, develops and commercializes lifesaving medicines for patients with ultra-rare, life-threatening disorders. As senior vice president and chief legal officer of Alexion, Tom led legal, government affairs, pricing and reimbursement, corporate communications and other functions, and he held commercial responsibility for the company’s Australasia region. Prior to Alexion, Tom served as vice president, general counsel and secretary of ChiRex, Inc., an international corporation providing advanced process development services and specialty manufacturing to the pharmaceutical industry. Earlier in his career, he held various positions with Warner-Lambert Company. Tom began his career as a corporate attorney with Cravath, Swaine & Moore in New York City. He received his J.D. from New York University, where he received the American Jurisprudence Prize in securities law, and his B.A. from Amherst College, cum laude. Tom has served on the board and executive committee of Temple B’nai Chaim in Georgetown, Connecticut, including a stint as chair of the synagogue’s 2014 rabbinic search committee. He is married to Pam Klem, and they live with their three children and dog in Wilton, Connecticut.